Clinical trial
Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial…
NCT00085202 · St. Jude Children's Research Hospital, Other · Completed
Key facts
| NCT number | NCT00085202 |
|---|---|
| Title | Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor |
| Official title | Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor |
| Lead sponsor | St. Jude Children's Research Hospital, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | filgrastim, cisplatin, cyclophosphamide, vincristine, autologous hematopoietic stem cell transplantation, radiation therapy |
| Enrollment | 416 |
| Start date | Aug 1, 2003 |
| Primary completion | Dec 1, 2016 |
| Completion | Dec 31, 2023 |
| First posted | Jun 11, 2004 |
| Last update posted | Feb 8, 2024 |
| Countries | Australia, Canada, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: